Unjha Formulations Stock Screener | Share Price & Fundamental Analysis

Share Price BSE
₹20.00
▼ -0.30 (-1.48%)
2026-03-09 00:00:00
Track Unjha Formulations share price live with TickJournal's free stock screener. Analyze Unjha Formulations share price history trends and compare 52-week high low levels. Calculate UNJHAFOR stock fair value using fundamental analysis and view live share price charts. Determine Unjha Formulations share intrinsic value and compare it with current UNJHAFOR share price. Record your Unjha Formulations trades in TickJournal's free trading journal and track your portfolio performance.
EPS (TTM) ₹0.91
Dividend Yield -
Debt to Equity -
Unjha Formulations 52 Week Low ₹20.00
Operating Margin 6.00%
Profit Margin 7.14%
EBITDA ₹1.00
Net Income ₹1.00
Total Assets ₹5.00
Total Equity ₹3.00

Unjha Formulations Share Price History - Stock Screener Chart

Screen UNJHAFOR historical share price movements with interactive charts. Analyze price trends and patterns.

Unjha Formulations Company Profile - Fundamental Screener

Screen Unjha Formulations company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for UNJHAFOR shares.
Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E
ISIN INE576D01015

Unjha Formulations Balance Sheet Screener

Screen UNJHAFOR balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Assets
Total Assets 5 5 3 4 4 4 4 4 4 3
Current Assets 3 4 2 2 2 3 3 3 2 2
Fixed Assets 1 1 1 1 1 1 1 1 1 1
Liabilities
Total Liabilities 5 5 3 4 4 4 4 4 4 3
Current Liabilities 0 0 0 0 0 0 0 0 0 0
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0
Shareholders' Equity
Total Equity 3 3 3 2 2 2 2 1 1 1
Share Capital 5 5 5 5 5 5 5 5 5 5
Reserves & Surplus -1 -2 -2 -2 -3 -3 -3 -3 -4 -4

Unjha Formulations Income Statement Screener - Profit & Revenue Analysis

Screen Unjha Formulations income statement and profit fundamentals. Analyze UNJHAFOR quarterly results, revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Unjha Formulations share price evaluation.
Item None-None 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March 2015-March
Revenue 14 14 19 13 14 10 11 12 11 12 10 9
Expenses 13 13 18 13 14 10 10 11 11 12 10 9
EBITDA 1 1 1 1 1 0 1 0 0 1 0 0
Operating Profit % 6.00% 4.00% 3.00% 3.00% 2.00% 1.00% 2.00% 3.00% 3.00% 3.00% 4.00% 2.00%
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 1 1 1 0 0 0 0 0 0 0 0 0
Tax 0 0 0 0 0 0 0 0 0 0 0 0
Net Profit 1 0 0 0 0 0 0 0 0 0 0 0
EPS 2.30 0.91 0.62 0.63 0.56 0.23 0.69 0.67 0.59 0.66 0.57 0.39

Unjha Formulations Cash Flow Screener - Liquidity Fundamentals

Screen UNJHAFOR cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March
Operating Activities 0 1 0 0 -1 0 0 0 0 0
Investing Activities 0 0 0 0 0 0 0 0 0 0
Financing Activities 0 0 0 0 0 0 0 0 0 0
Net Cash Flow 0 1 0 0 -1 0 0 0 0 0

Unjha Formulations Shareholding Pattern Screener

See Unjha Formulations shareholding pattern with promoter, FII, and DII holdings. Check Unjha Formulations promoter holding and ownership changes for UNJHAFOR on TickJournal.
Item 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept 2024-Jun 2024-Mar 2023-Dec
Promoter Holding 36.92% 36.92% 36.92% 36.92% 36.92% 36.92% 36.92% 36.92%
FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 56.19% 56.10% 56.80% 56.61% 56.90% 57.78% 58.13% 59.14%
Other Holding 6.88% 6.98% 6.28% 6.47% 6.17% 5.30% 4.95% 3.94%
Shareholder Count 4,284 4,213 4,273 4,208 3,969 3,985 3,933 4,012

Unjha Formulations Share Dividend Screener - Share Yield Analysis

Check Unjha Formulations dividend history with payout and yield data. View Unjha Formulations dividend details including ex-dates and amounts for UNJHAFOR stock.
No dividends declared by Unjha Formulations.

Unjha Formulations Stock Index Membership

See which indices include Unjha Formulations stock. Check UNJHAFOR index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Unjha Formulations is not part of any tracked indices.
Only major market indices are tracked in our system.

Unjha Formulations Market Events Screener - Corporate Actions

Get Unjha Formulations corporate actions including splits, bonuses, and buybacks. Check Unjha Formulations stock events that may affect UNJHAFOR share price.
Announcement Date Record Date Event Type Information Price Impact
2025-11-10 2025-11-10 Quarterly Result Announcement NA -2.76%
2025-08-13 2025-08-13 Annual General Meeting NA 2.42%
2025-08-06 2025-08-06 Quarterly Result Announcement NA -3.52%
2025-05-16 2025-05-16 Quarterly Result Announcement NA -1.32%
2025-02-04 2025-02-04 Quarterly Result Announcement NA -2.81%
2024-11-08 2024-11-08 Quarterly Result Announcement NA 12.80%
2024-08-16 2024-08-16 Annual General Meeting NA 12.61%

Unjha Formulations Competitors Screener - Peer Comparison

Screen UNJHAFOR competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 421,299 40.53 54,729 9.71% 10,980 46.18
Divis Laboratories 171,931 69.57 9,712 18.67% 2,191 53.62
Torrent Pharmaceuticals 129,290 60.33 11,539 6.99% 1,911 62.04
Cipla 121,220 22.48 28,410 7.12% 5,291 44.91
Dr Reddys Laboratories 107,123 18.68 33,741 16.73% 5,725 60.09
Lupin 96,535 22.34 22,910 13.74% 3,306 60.88
Zydus Life Science 93,358 18.37 23,511 18.55% 4,615 47.29
Mankind Pharma 92,029 50.91 12,744 20.90% 2,007 53.62
Aurobindo Pharma 70,742 20.79 32,346 9.43% 3,484 57.50
Alkem Laboratories 66,921 27.88 13,458 3.70% 2,216 47.48

Unjha Formulations Company Announcements - News Screener

Screen UNJHAFOR latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
2025-11-12 Publish Un-Audited Financial Results For The Quarter & Half Year Ended As On 30/09/2025 View
2025-11-10 Approval Of Un-Audited Financial Results Of The Company For Quarter Ended And Half Year Ended On 30Th September2025 And Out Come Of Board Meeting Held On 10Th November 2025 View
2025-11-10 Board Meeting Outcome for : Approval Of Un-Audited Financial Results Of The Company For Quarter Ended And Half Year Ended On 30Th September2025 And Out Come Of Board Meeting Held On 10Th November 2025 View
2025-10-29 Board Meeting Intimation for Board Meeting - Date: 10.11.2025 (Un-Audited Financial Results For The Half Year And Quarter Ended On 30.09.2025) View
2025-10-10 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 View
2025-10-01 Board Meeting Outcome for Outcome Of Board Meeting - Appointment Of Company Secretary And Compliance Officer View
2025-09-05 Submissions Of XML File For Financial Statement I.E. Balance Sheet P&L Accounts And Cash Flow Statement As On 31.03.2025 (AGM Held On 13/08/2025) As Per SEBI (Listing Obligation And Disclosure Requirements) Regulations2015 View
2025-08-13 Filing Of Distribution Schedule View
2025-08-13 Cash Flow Statement For The Year Ended 31.03.2025 View
2025-08-13 Intimation Under Regulation 30 Read With Part A Of The Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) (LODR) Regulations 2015 View
2025-08-13 Regulation 44(3) Of The SEBI (Listing Obligation And Disclosure Requirements) I.E. Voting Results View
2025-08-13 Shareholder Meeting / Postal Ballot-Scrutinizers Report View
2025-08-13 Shareholder Meeting / Postal Ballot-Outcome of AGM View
2025-08-07 Publish Un-Audited Financial Results For The Quarter Ended As On 30/06/2025 View
2025-08-06 Approval Of Un-Audited Financial Results Of The Company For First Quarter Ended On 30Th June 2025 And Out Come Of Board Meeting Held On 6Th August 2025 View
2025-08-06 Board Meeting Outcome for Approval Of Un-Audited Financial Results Of The Company For First Quarter Ended On 30Th June 2025 And Out Come Of Board Meeting Held On 6Th August 2025 View
2025-07-29 E- Voting Facility At The Forthcoming Annual General Meeting & Intimation Of Fixation Of Cut-Off Date View
2025-07-21 Board Meeting Intimation for Board Meeting - Date: 06.08.2025( Un-Audited Financial Results For The Quarter Ended On 30.06.2025) View
2025-07-18 Regulation 47 Of SEBI(LODR) Regulations 2015.Published Notice Of AGM View
2025-07-17 Regulation 30 & 34(1) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015 View